1. Cystic Fibrosis: http://www.pulmonologychannel.com/Cystic Fibrosis/#stats

 

2.  Ammon HP, et al. Pharmacology of Curcuma longa. Planta Med. Feb1991;57(1):1-7.
 

3.  Ammon HP, et al. Mechanism of Anti-inflammatory Actions of Curcumin and Boswellic Acids. J Ethnopharmacol. 1993;38: 113.
 

4. Satoskar RR et al., "Evaluation of anti-inflammatory property of curcumin (diferuloy  methane) in patients with postoperative inflammation," Int J Clin Pharmacol Ther Toxicol 1986 (24): 651-4.
 

5. Srivastava KC, et al. Curcumin, A Major Component of Food Spice Turmeric (Curcuma longa) Inhibits Aggregation and Alters Eicosanoid Metabolism In Human Blood Platelets. Prostaglandins Leukot Essent Fatty Acids. Apr1995;52(4): 223-27.
 

6. Egan ME, Pearson M, Weiner SA, et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science. 2004 Apr 23;304(5670):600-2.

 

7. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (ecos apentanoic and docosahexanoic) in patients with cystic fibrosis. J Parenter Enteral Nutr. Jan-Feb 2003;27(1):52-57.

 

8. Schwartz J, Weiss ST. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Examination Survey (NHANES I). Eur Respir J 1994;7:1821–4.

 

9. Schwartz J Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr. Jan 2000;71(1 Suppl): 393S-396S.

 

10.  Back EI et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am J Clin Nutr. 2004 Aug;80(2):374-84.

 

11. Winklhofer-Roob BM et al. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of asssociations with lung inflammation. Am J Clin Nutr 1997 65(6): 1858-66.

 

12. Hunt C et al. "The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections," Int J Vitam Nutr Res 1994 (64): 212-9.

 

13. Amarri S et al. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child Apr 1997 76 (4): 349-51

 

14.  Saavedra, J.M. Clinical applications of probiotic agents. Am. J. Clin. Nutr. 2001 Jun; 73(6): 1147S-1151S.

 

15. James F. Balch and Phyllis A. Balch, Prescription for Nutritional Healing, 3rd ed. (New York, NY: Penguin Putnam Avery, 2000): 221.

 

16. Riise GC, et al. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J. Jan1994;7(1):94-101.
 

17. Tattersall AB, et al. Acetylcysteine (Fabrol) in chronic bronchitis--a study in general practice. J Int Med Res. 1983;11(5):279-84.
 

18. Corradi M et al. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med. 2001 Mar;163(4):854-8.

 

19.  Millman M, et al. Use of acetylcysteine in bronchial asthma--another look. Ann Allergy. Apr1985;54(4):294-6.
 

20. Grandjean EM, et al. Cost-effectiveness analysis of oral n-acetylcysteine as a preventive treatment in chronic bronchitis. Pharmacol Res Jul2000;42(1):39-50.

 

21. Pizzorno JE and Murray MT, eds. Encyclopedia of Natural Medicine, revised 2nd edition, CA: Prima Publishing, 1998: 297

 

22. Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001 Aug;58(9):1234-45.

 

23. Stoppard M. Family Health Guide, New York: DK Publishing, 2002

 

24. Merck Manual eds, The Merck Manual of Diagnosis and Therapy, 15th edtion, Rahway, NJ: Merck & Co., Inc, 1997.